Hypomethylation status of CDK1 in some tumors may lead to activation of other oncogenes, while hypermethylation status in other tumors may further exacerbate carcinogenesis by silencing tumor-associated suppressor genes. The gene discussed is CDK1; the disease is neoplasm.